Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Clement, Karine

van den Akker, Erica

Argente, Jesus

Bahm, Allison

Chung, Wendy K.

et al.

Institutions

UKU. Klinik für Kinder- und Jugendmedizin

Published in

Lancet Diabetes & Endocrinology ; 8 (2020), 12. - S. 960-970. - ISSN 2213-8587. - eISSN 2213-8595

Link to publication

https://dx.doi.org/10.1016/S2213-8587(20)30364-8

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record